IPO Comments to USPTO on 2024 Guidance Update on Patent Subject Matter Eligibility, Including on Artificial Intelligence
IPO Comments to USPTO on 2024 Guidance Update on Patent [...]
IPO Comments to USPTO on 2024 Guidance Update on Patent [...]
IPO Comments to CNIPA on Draft Model Text of Patent [...]
IPOwners Quarterly™ 10/8/2024
IPO Comments to USTR Regarding 2024 Notorious Markets
RESOLVED, IPO opposes the Medication Affordability and Patent Integrity Act [...]
IPO Comments to CNIPA on Draft Measures for Administrative Adjudication [...]
IPO Comments to CNIPA on Draft Provisions on Procedures for [...]
IPO Comments to USPTO on Impact of Proliferation of AI [...]
IPO Comments to USPTO Regarding Terminal Disclaimer Practice to Obviate [...]
IPO Comments to USPTO on Negotiations at the World Intellectual [...]